Effects of ATP-MgCl2 administration in hypovolemic dogs

Panminerva Medica

Volumn 41, Issue , 1999, Pages 323-330

  Katircioglu S F ^a   Ulus, A T ^b   Saritas, Z ^b   Gokce P ^b  

^a Ilkiz Sok   (Turkey)

^b NONE

Author keywords

ATP MgCl2; Hemorrhage; Shock

Indexed keywords

ADENOSINE TRIPHOSPHATE; MAGNESIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; DOG; DRUG EFFECT; DRUG POTENTIATION; HEMODYNAMICS; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; SECRETION; SHOCK;

ADENOSINE TRIPHOSPHATE; ANIMALS; DOGS; HEMODYNAMIC PROCESSES; MAGNESIUM CHLORIDE; OXYGEN CONSUMPTION; SHOCK; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033250729     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Prasad K, Kapoor R, Kalra J. Methionine in protection of hemorrhagic shock: Role of oxygen free radicals and hypochlorous acts. Circ Shock 1992;36:265-76.
2. Horton JW. Hemorrhagic shock depresses myocardial contractile function in guinea pig. Circ Shock 1989;28:23-36.
3. Chaudry IH, Sayeed MM, Baue AK. Depletion and restoration of tissues ATP in hemorrhagic shock. Arch Surg 1974;108:208-11.
4. Lefer AM. Properties of cardioinhibitory factors produced in shock. Fed Proc 1978;37:2734-40.
5. Chambers DE, Parks DA, Patterson G, Roy R, McCord JM, Yoshida et al. Xanthine oxidase as a source of free radical damage in myocardial ischemia. J Mol Cell Cardiol 1985;17:145-52.
6. Jenning RB, Reimer KA. Lethal myocardial ischemic injury. Am J Pathol 1982;102:241-55.
7. Brasmer TH. Fluid therapy in shock. J Am Vet Med Assoc 1979;174:475-8.
8. Okrasinski EB, Krahwinkel DJ, Sandres WL. Treatment of dogs in hemorrhagic shock by intraosseous infusion of hypertonic saline and dextran. Vet Surg 1992;21:20-4.
9. Concannon KT, Haskins SG, Feldman BF. Hemostatic defects associated with two infusion rates of dcxtran 70 in dogs. Am J Vet Res 1992;53:1396-402.
10. Hankes GH, Dillon AR, Ravis WR. Effects of lactated ringer solution and prednisolone sodium succinate on dogs with induced hemorrhagic shock. Am J Vet Res 1992;53:26-33.
11. Schertel ER, Allen DA, Muir WW, Hansen BD. Evaluation of a hypertonic sodium chloride/dextran solution for treatment of traumatic shock in dogs. J Am Vet Med Assoc 1996;208:366-70.
12. Dupe R, Bywater RJ, Goddard. A hypertonic infusion in the treatment of experimental shock in calves and clinical shock in dogs and cats. Vet Rec 1993;133:585-90.
13. 2 in canine hemorrhagic shock. Surg Gynecol Obstet 1980;160:195.
14. 2 following trauma-hemorrhage and resuscitation: Downregulation of inflammatory cytokine (TNF, IL-6) release. J Surg Res 1992;52:364-71.
15. Horpasey G, Schnells G. Metabolism of adenine nucleotides in the kidney during hemorrhagic hypotension and after recovery. J Surg Res 1980;29:11-7.
16. Chaudry IH, Sayeed MM, Baue. Effect of hemorrhagic shock on tissue adenine nucleotides in conscious rats. Can J Physiol Pharmacol 1974;52:131-47.
17. Smart CJ, Rowlands SD. Oxygen consumption and hepatic metabolism in experimental posthemorrhagic shock. J Trauma 1972;12:327-34.
18. Baue AK, Wurth Sayeed MM. The dynamics of altered ATP-dependent and ATP yielding cell process in shock. Surgery 1972;72: 94-101.
19. Chaudry IH, Okhawa M, Clemens MG, Baue AE. Alterations in electron transport cellular metabolism in shock and trauma. In: Lefer AM, Schumer W, editors. Molecular and cellular aspects of shock and trauma. New York: Alan R Liss, 1983:67-83.
20. Horton JW, White DJ. Free radical scavengers prevent intestinal ischemia-reperfusion-mediated cardiac dysfunction. J Surg Res 1993;55:282-9.
21. Pohlman TH, Stanness KA, Beatty PG, Ochs HD, Harlan JM. An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin-11 and tumor necrosis factor increases neutrophil adherence by a Cdw 18-dependent mechanism. J Immunol 1986;136:4548-53.
22. Tsujimoto M, Yokata S, Vilcek J, Weissmann G. Tumor necrosis factor provokes superoxide anion generation from neutrophils. Biochem Biophys Res Comm 1986;137:1094-8.
23. Bevilacqua MP, Wheeler ME, Pober JS. Endothelial-dependent mechanism of leukocyte adhesion: regulation by interleukin-1 and tumor necrosis factor. In: Movat Hz, editor. Leukocyte emigration and its sequelae. New York: Karger, 1979:179.
24. Meyer JD, Yurt RW, Duhaney R. Tumor necrosis factor-enhanced leukotriene B4 generation and chemotaxis in human neutrophils. Arch Surg 1988;123:1454-8.
25. Shalaby MR, Aggarwal BB, Rinderknecht E, Svedersky LP, Finkle BS, Palladino MA. Activation of human polymorphonuclear neutrophil function by interferon gamma and tumor necrosis factor. J Immunol 1985;135:2069.
26. 2 infusion on hepatic cell permeability and metabolism following hemorrhagic shock. Surgery 1981;90:328-35.
27. 2. Surg Forum 1980;31:10-2.
28. 2 after ischemia. Abstr Circ Shock 1982;9:162-3.
29. Harkema JM, Chaudry IH. Magnesium-adenosine triphosphate in the treatment of shock, ischemia, and sepsis. Crit Care Med 1992;20(2):263-75.
30. Altura BM, Altura BT. Magnesium vascular tone and reactivity. Blood vessels 1978;15(5):5-16.
31. Chaudry IH, Stephan RN, Dean RE, Clemens G, Baue AE. Use of magnesium-ATP following liver ischemia. Magnesium 1988;7:68-77.
32. Chaudry IH, Sayeed MM, Baue AK. Effect of adenosine triphosphate-magnesium chloride administration in shock. Surgery 1974;75:220-7.
33. 2 following hemorrhagic shock. Circ Shock 1983;11:141-8.
34. Cikrit D, Gross K, Kats S, Plager D, Rose D, Wolf M et al. Comparative effects of cytoprotective agents in bowel ischemia. Surg Forum 1983;34:208.
35. 2 on renal function following ischemia. Am J Physiol 1987;252:R388-93.
36. 2 after warm ischemia. Am J Physiol 1984;247:R1047-53.
37. 2 infusion on hepatic cell permeability and metabolism after hemorrhagic shock. Surgery 1981;90:328-35.
38. Sumpio BE, Chaudry IH, Baue AE. Adenosine triphosphate-magnesium chloride ameliorates reperfusion injury following ischemia as determined by phosphorus nuclear magnetic resonance. Arch Surg 1985;120:233-40.
39. 2. Adv Shock Res 1982;8:177-86.
40. 2 determined by 34P-NMR. Am J Physiol 1983;245:F530-4.
41. 2. Am J Physiol 1984;246:R799-R804.
42. 2 produces sustained improvement in hepatic mitochondrial function and blood flow after hepatic ischemia. J Surg Res 1984;37:226-34.
43. 2 treatment. Am J Physiol 1985;248:H804-H811.
44. 2 delivery. J Appl Physiol 1991;71(1):83-93.
45. 2 uptake during bacteremia in dogs. J Appl Physiol 1987;63:1487-92:
46. Husser F, Fahey JT, Lister G. Effect of hemoglobin concentration on critical cardiac output and oxygen transport. Am J Physiol 1989;256:H527-32.
47. Tracey KJ, Lowry SF, Fahey TY, Albert JD, Fong Y, Hesse D et al. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg Gynecol Obstet 1987;164:415-22.
48. Zingarelli B, Squadrito F, Altavilla D, Calapani G, Di Vosa M, Caputi AP. Role of tumor necrosis factor-α in acute hypovolemic hemorrhagic shock in rats. Am J Physiol 1994;266:H1512-15.
49. Green EM, Adams HR. New perspectives in circulatory shock: Pathophysiologic mediators of the mammalian response to endotoxemia and sepsis. J Am Vet Med Assoc 1992;200(12):1834-41.
50. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC et al. Anti-cachectine/TNF monoclonal antibodies prevent shock during lethal bacteriemia. Nature 1987;330:662-4.
51. Shimamato Y, Chen RL, Ballon A, Chang A, Khan A. Monoclonal antibodies against human recombinant tumor necrosis factor: prevention of endotoxic shock. Immunol Lett 1988;17:311-8.